Stay updated on Apatinib Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.

Latest updates to the Apatinib Plus Pembrolizumab Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page's revision/version label was updated from v3.6.2 to v3.6.3, reflecting a minor update to the page's metadata.SummaryDifference0.1%

- Check19 days agoChange DetectedThe site revision was updated from v3.6.0 to v3.6.2, reflecting a platform-level update rather than changes to the study details displayed on the page.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page now notes that recruitment is closed, and adds user guidance sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'; a formatting change to the Intervention/Treatment header and a revision tag update are also included.SummaryDifference0.6%

- Check41 days agoChange DetectedRevision: v3.5.5 is now shown, updating the document's version. It represents a small metadata update rather than a change to the study details.SummaryDifference0.1%

- Check62 days agoChange DetectedThe revision label on the page changed from v3.5.3 to v3.5.4, indicating an update to the site; no study content or critical data was altered.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page now shows Revision: v3.5.3, replacing Revision: v3.5.2. This reflects a minor site/version update rather than any changes to the study details.SummaryDifference0.1%

Stay in the know with updates to Apatinib Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.